BiotechTube

Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + warfarin

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Atrial Fibrillation

Conditions

Atrial Fibrillation, Thromboembolism

Trial Timeline

Jun 1, 2007 → Jun 1, 2008

NCT ID
NCT00504556

About Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + warfarin

Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + warfarin is a phase 2 stage product being developed by Daiichi Sankyo for Atrial Fibrillation. The current trial status is completed. This product is registered under clinical trial identifier NCT00504556. Target conditions include Atrial Fibrillation, Thromboembolism.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00504556Phase 2Completed

Competing Products

20 competing products in Atrial Fibrillation

See all competitors
ProductCompanyStageHype Score
EdoxabanDaiichi SankyoPre-clinical
23
Edoxaban + Clopidogrel + Prasugrel + Ticagrelor + Vitamin K antagonistDaiichi SankyoPhase 3
77
OAC aloneDaiichi SankyoApproved
85
Edoxaban + ASADaiichi SankyoPhase 3
77
DU-176b tablets + DU-176b tablets + Warfarin tabletsDaiichi SankyoPhase 2
52
Edoxaban + Apixaban + RivaroxabanDaiichi SankyoPre-clinical
23
Edoxaban + VKA-Based Regimen + VKA-Based Regimen + VKA-Based Regimen + VKA-Based RegimenDaiichi SankyoPhase 3
77
EdoxabanDaiichi SankyoPre-clinical
23
EdoxabanDaiichi SankyoApproved
85
Edoxaban + Warfarin + EnoxaparinDaiichi SankyoPhase 3
77
EdoxabanDaiichi SankyoPre-clinical
23
EdoxabanDaiichi SankyoPre-clinical
23
DU-176b 15mg + DU-176b 30mg + DU-176b 60mgDaiichi SankyoPhase 3
77
dabigatran, rivaroxaban, apixaban or edoxabanDaiichi SankyoPre-clinical
23
EdoxabanDaiichi SankyoPre-clinical
23
DU-176b tablets + Warfarin potassium tabletsDaiichi SankyoPhase 2
52
Edoxaban-based Regimen + VKA-based RegimenDaiichi SankyoPhase 3
77
EdoxabanDaiichi SankyoPre-clinical
23
Edoxaban + Aspirin and Clopidogrel + Aspirin and WarfarinDaiichi SankyoApproved
85
EdoxabanDaiichi SankyoPre-clinical
23

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85